Effects of HMG-CoA Reductase Inhibitors on Cardiovascular Events and Renal Function in Patients with Chronic Kidney Disease
碩士 === 高雄醫學大學 === 臨床藥學研究所 === 101 === Background: In Taiwan, the prevalence of chronic kidney disease (CKD) among adult is 12%. CKD is one of the risk factors of cardiovascular disease (CVD). HMG-CoA reductase inhibitors (statin) is the first-line agent for treatment of hypercholesterolemia. There a...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2012
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/29967318275485345655 |